Company Filing History:
Years Active: 2018
Title: Sandeep Kumar Thoota: Innovator in Anticancer Drug Development
Introduction
Sandeep Kumar Thoota is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer drugs. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Sandeep Kumar Thoota holds a patent for "7-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugs." This invention relates to a novel series of substituted 7-(morpholinyl)-2-(N-piperazinyl)-methyl thieno [2, 3-c] pyridines, which are designed to combat cancer effectively. The patent outlines the specific structure of these compounds, where R1, R2, R3, and R4 are defined, highlighting the innovative approach taken in this research.
Career Highlights
Sandeep Kumar Thoota is currently employed at Natco Pharma Limited, a prominent pharmaceutical company known for its commitment to developing high-quality medicines. His role at Natco Pharma has allowed him to work on groundbreaking projects that aim to address critical health challenges, particularly in oncology.
Collaborations
Throughout his career, Sandeep